Musculoskeletal manifestations in children with Behçet's syndrome : data from the AIDA Network Behçet's Syndrome Registry
© 2023. The Author(s)..
This study aims to describe musculoskeletal manifestations (MSM) in children with Behçet's syndrome (BS), their association with other disease manifestations, response to therapy, and long-term prognosis. Data were retrieved from the AIDA Network Behçet's Syndrome Registry. Out of a total of 141 patients with juvenile BS, 37 had MSM at disease onset (26.2%). The median age at onset was 10.0 years (IQR 7.7). The median follow-up duration was 21.8 years (IQR 23.3). Recurrent oral (100%) and genital ulcers (67.6%) and pseudofolliculitis (56.8%) were the most common symptoms associated with MSM. At disease onset, 31 subjects had arthritis (83.8%), 33 arthralgia (89.2%), and 14 myalgia (37.8%). Arthritis was monoarticular in 9/31 cases (29%), oligoarticular in 10 (32.3%), polyarticular in 5 (16.1%), axial in 7 (22.6%). Over time, arthritis became chronic-recurrent in 67.7% of cases and 7/31 patients had joint erosions (22.6%). The median Behçet's Syndrome Overall Damage Index was 0 (range 0-4). Colchicine was inefficacious for MSM in 4/14 cases (28.6%), independently from the type of MSM (p = 0.46) or the concomitant therapy (p = 0.30 for cDMARDs, p = 1.00 for glucocorticoids); cDMARDs and bDMARDs were inefficacious for MSM in 6/19 (31.4%) and 5/12 (41.7%) cases. The presence of myalgia was associated with bDMARDs inefficacy (p = 0.014). To conclude, MSM in children with BS are frequently associated with recurrent ulcers and pseudofolliculitis. Arthritis is mostly mono- or oligoarticular, but sacroiliitis is not unusual. Prognosis of this subset of BS is overall favorable, though the presence of myalgia negatively affects response to biologic therapies. ClinicalTrials.gov Identifier: NCT05200715 (registered on December 18, 2021).
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:18 |
|---|---|
| Enthalten in: |
Internal and emergency medicine - 18(2023), 3 vom: 07. Apr., Seite 743-754 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
Arthritis |
|---|
| Anmerkungen: |
Date Completed 12.04.2023 Date Revised 15.07.2023 published: Print-Electronic ClinicalTrials.gov: NCT05200715 Citation Status MEDLINE |
|---|
| doi: |
10.1007/s11739-023-03215-w |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM353870765 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM353870765 | ||
| 003 | DE-627 | ||
| 005 | 20231226061013.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11739-023-03215-w |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1179.xml |
| 035 | |a (DE-627)NLM353870765 | ||
| 035 | |a (NLM)36881285 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Gaggiano, Carla |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Musculoskeletal manifestations in children with Behçet's syndrome |b data from the AIDA Network Behçet's Syndrome Registry |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 12.04.2023 | ||
| 500 | |a Date Revised 15.07.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ClinicalTrials.gov: NCT05200715 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. The Author(s). | ||
| 520 | |a This study aims to describe musculoskeletal manifestations (MSM) in children with Behçet's syndrome (BS), their association with other disease manifestations, response to therapy, and long-term prognosis. Data were retrieved from the AIDA Network Behçet's Syndrome Registry. Out of a total of 141 patients with juvenile BS, 37 had MSM at disease onset (26.2%). The median age at onset was 10.0 years (IQR 7.7). The median follow-up duration was 21.8 years (IQR 23.3). Recurrent oral (100%) and genital ulcers (67.6%) and pseudofolliculitis (56.8%) were the most common symptoms associated with MSM. At disease onset, 31 subjects had arthritis (83.8%), 33 arthralgia (89.2%), and 14 myalgia (37.8%). Arthritis was monoarticular in 9/31 cases (29%), oligoarticular in 10 (32.3%), polyarticular in 5 (16.1%), axial in 7 (22.6%). Over time, arthritis became chronic-recurrent in 67.7% of cases and 7/31 patients had joint erosions (22.6%). The median Behçet's Syndrome Overall Damage Index was 0 (range 0-4). Colchicine was inefficacious for MSM in 4/14 cases (28.6%), independently from the type of MSM (p = 0.46) or the concomitant therapy (p = 0.30 for cDMARDs, p = 1.00 for glucocorticoids); cDMARDs and bDMARDs were inefficacious for MSM in 6/19 (31.4%) and 5/12 (41.7%) cases. The presence of myalgia was associated with bDMARDs inefficacy (p = 0.014). To conclude, MSM in children with BS are frequently associated with recurrent ulcers and pseudofolliculitis. Arthritis is mostly mono- or oligoarticular, but sacroiliitis is not unusual. Prognosis of this subset of BS is overall favorable, though the presence of myalgia negatively affects response to biologic therapies. ClinicalTrials.gov Identifier: NCT05200715 (registered on December 18, 2021) | ||
| 650 | 4 | |a Clinical Trial | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Arthritis | |
| 650 | 4 | |a Behçet’s syndrome | |
| 650 | 4 | |a International registry | |
| 650 | 4 | |a Pediatric rheumatology | |
| 650 | 4 | |a Rare diseases | |
| 700 | 1 | |a Maselli, Anna |e verfasserin |4 aut | |
| 700 | 1 | |a Sfikakis, Petros P |e verfasserin |4 aut | |
| 700 | 1 | |a Laskari, Katerina |e verfasserin |4 aut | |
| 700 | 1 | |a Ragab, Gaafar |e verfasserin |4 aut | |
| 700 | 1 | |a Hegazy, Mohamed Tharwat |e verfasserin |4 aut | |
| 700 | 1 | |a Laymouna, Ahmed Hatem |e verfasserin |4 aut | |
| 700 | 1 | |a Lopalco, Giuseppe |e verfasserin |4 aut | |
| 700 | 1 | |a Almaghlouth, Ibrahim A |e verfasserin |4 aut | |
| 700 | 1 | |a Asfina, Kazi Nur |e verfasserin |4 aut | |
| 700 | 1 | |a Alahmed, Ohoud |e verfasserin |4 aut | |
| 700 | 1 | |a Giardini Mayrink, Henrique Ayres |e verfasserin |4 aut | |
| 700 | 1 | |a Parente de Brito Antonelli, Isabele |e verfasserin |4 aut | |
| 700 | 1 | |a Cattalini, Marco |e verfasserin |4 aut | |
| 700 | 1 | |a Piga, Matteo |e verfasserin |4 aut | |
| 700 | 1 | |a Sota, Jurgen |e verfasserin |4 aut | |
| 700 | 1 | |a Gentileschi, Stefano |e verfasserin |4 aut | |
| 700 | 1 | |a Maggio, Maria Cristina |e verfasserin |4 aut | |
| 700 | 1 | |a Opris-Belinski, Daniela |e verfasserin |4 aut | |
| 700 | 1 | |a Hatemi, Gülen |e verfasserin |4 aut | |
| 700 | 1 | |a Insalaco, Antonella |e verfasserin |4 aut | |
| 700 | 1 | |a Olivieri, Alma Nunzia |e verfasserin |4 aut | |
| 700 | 1 | |a Tufan, Abdurrahman |e verfasserin |4 aut | |
| 700 | 1 | |a Karadeniz, Hazan |e verfasserin |4 aut | |
| 700 | 1 | |a Kardaş, Riza Can |e verfasserin |4 aut | |
| 700 | 1 | |a La Torre, Francesco |e verfasserin |4 aut | |
| 700 | 1 | |a Cardinale, Fabio |e verfasserin |4 aut | |
| 700 | 1 | |a Marino, Achille |e verfasserin |4 aut | |
| 700 | 1 | |a Guerriero, Silvana |e verfasserin |4 aut | |
| 700 | 1 | |a Ruscitti, Piero |e verfasserin |4 aut | |
| 700 | 1 | |a Tarsia, Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Vitale, Antonio |e verfasserin |4 aut | |
| 700 | 1 | |a Caggiano, Valeria |e verfasserin |4 aut | |
| 700 | 1 | |a Telesca, Salvatore |e verfasserin |4 aut | |
| 700 | 1 | |a Iannone, Florenzo |e verfasserin |4 aut | |
| 700 | 1 | |a Parretti, Veronica |e verfasserin |4 aut | |
| 700 | 1 | |a Frassi, Micol |e verfasserin |4 aut | |
| 700 | 1 | |a Aragona, Emma |e verfasserin |4 aut | |
| 700 | 1 | |a Ciccia, Francesco |e verfasserin |4 aut | |
| 700 | 1 | |a Wiesik-Szewczyk, Ewa |e verfasserin |4 aut | |
| 700 | 1 | |a Ionescu, Ruxandra |e verfasserin |4 aut | |
| 700 | 1 | |a Şahin, Ali |e verfasserin |4 aut | |
| 700 | 1 | |a Akkoç, Nurullah |e verfasserin |4 aut | |
| 700 | 1 | |a Hinojosa-Azaola, Andrea |e verfasserin |4 aut | |
| 700 | 1 | |a Tharwat, Samar |e verfasserin |4 aut | |
| 700 | 1 | |a Hernández-Rodríguez, José |e verfasserin |4 aut | |
| 700 | 1 | |a Espinosa, Gerard |e verfasserin |4 aut | |
| 700 | 1 | |a Conti, Giovanni |e verfasserin |4 aut | |
| 700 | 1 | |a Del Giudice, Emanuela |e verfasserin |4 aut | |
| 700 | 1 | |a Govoni, Marcello |e verfasserin |4 aut | |
| 700 | 1 | |a Emmi, Giacomo |e verfasserin |4 aut | |
| 700 | 1 | |a Fabiani, Claudia |e verfasserin |4 aut | |
| 700 | 1 | |a Balistreri, Alberto |e verfasserin |4 aut | |
| 700 | 1 | |a Frediani, Bruno |e verfasserin |4 aut | |
| 700 | 1 | |a Rigante, Donato |e verfasserin |4 aut | |
| 700 | 1 | |a Cantarini, Luca |e verfasserin |4 aut | |
| 700 | 0 | |a AIDA Network |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Internal and emergency medicine |d 2006 |g 18(2023), 3 vom: 07. Apr., Seite 743-754 |w (DE-627)NLM165086432 |x 1828-0447 |7 nnns |
| 773 | 1 | 8 | |g volume:18 |g year:2023 |g number:3 |g day:07 |g month:04 |g pages:743-754 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s11739-023-03215-w |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 18 |j 2023 |e 3 |b 07 |c 04 |h 743-754 | ||